Mike Sampson

Summary

Affiliation: Norfolk and Norwich University Hospital
Country: UK

Publications

  1. ncbi Trends in bed occupancy for inpatients with diabetes before and after the introduction of a diabetes inpatient specialist nurse service
    M J Sampson
    Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
    Diabet Med 23:1008-15. 2006
  2. ncbi A national survey of in-patient diabetes services in the United Kingdom
    M J Sampson
    Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
    Diabet Med 24:643-9. 2007
  3. ncbi Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes
    Joanna R Worley
    School of Biological Sciences, University of East Anglia, Norwich, NR4 7TJ, UK
    Cardiovasc Diabetol 6:21. 2007
  4. ncbi Pro-oxidant effect of alpha-tocopherol in patients with type 2 diabetes after an oral glucose tolerance test--a randomised controlled trial
    Mark S Winterbone
    Institute of Food Research, Norwich Research Park, Norwich, NR4 7UA, UK
    Cardiovasc Diabetol 6:8. 2007
  5. ncbi Lack of association of colonic epithelium telomere length and oxidative DNA damage in Type 2 diabetes under good metabolic control
    Deepak Kejariwal
    Department of Gastroenterology, Norfolk and Norwich University Hospital Colney Lane, Norwich NR4 7UY, UK
    BMC Endocr Disord 8:12. 2008
  6. ncbi Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes
    M J Sampson
    School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7UA, UK
    Diabetologia 49:1726-31. 2006
  7. ncbi Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes
    Mike J Sampson
    Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital National Health Service Trust, Norwich NR4 7UA, UK
    Diabetes Care 29:283-9. 2006
  8. ncbi Monocyte matrix and ADAM metalloproteinase expression in type 2 diabetes after aspirin therapy
    Mike Sampson
    Bertram Diabetes Research Unit, Norfolk and Norwich University Hospital NHS Trust, Norwich NR4 7UY, UK
    Diabetes Res Clin Pract 71:45-51. 2006
  9. ncbi Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes
    Mike J Sampson
    Bertram Diabetes Research Unit, Norfolk and Norwich University Hospital, UK
    Clin Sci (Lond) 109:189-97. 2005
  10. ncbi A mobile screening programme for the cardiovascular and microvascular complications of Type 2 diabetes in primary care
    M J Sampson
    Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital, Norwich, UK
    Diabet Med 22:256-7. 2005

Detail Information

Publications20

  1. ncbi Trends in bed occupancy for inpatients with diabetes before and after the introduction of a diabetes inpatient specialist nurse service
    M J Sampson
    Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
    Diabet Med 23:1008-15. 2006
    ..To compare diabetes bed occupancy and inpatient length of stay, before and after the introduction of a dedicated diabetes inpatient specialist nurse (DISN) service in a large UK Hospital...
  2. ncbi A national survey of in-patient diabetes services in the United Kingdom
    M J Sampson
    Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
    Diabet Med 24:643-9. 2007
    ..To examine in-patient diabetes services in all UK acute hospitals...
  3. ncbi Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes
    Joanna R Worley
    School of Biological Sciences, University of East Anglia, Norwich, NR4 7TJ, UK
    Cardiovasc Diabetol 6:21. 2007
    ..We hypothesised that plasma low density lipoprotein [LDL] from subjects with Type 2 diabetes would influence in vitro monocytic ADAM and matrix metalloproteinase [MMP] gene expression differently compared to control LDL...
  4. ncbi Pro-oxidant effect of alpha-tocopherol in patients with type 2 diabetes after an oral glucose tolerance test--a randomised controlled trial
    Mark S Winterbone
    Institute of Food Research, Norwich Research Park, Norwich, NR4 7UA, UK
    Cardiovasc Diabetol 6:8. 2007
    ....
  5. ncbi Lack of association of colonic epithelium telomere length and oxidative DNA damage in Type 2 diabetes under good metabolic control
    Deepak Kejariwal
    Department of Gastroenterology, Norfolk and Norwich University Hospital Colney Lane, Norwich NR4 7UY, UK
    BMC Endocr Disord 8:12. 2008
    ..We hypothesised that the colonic mucosa in Type 2 diabetes would be characterised by increased DNA damage and telomere shortening...
  6. ncbi Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes
    M J Sampson
    School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7UA, UK
    Diabetologia 49:1726-31. 2006
    ....
  7. ncbi Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes
    Mike J Sampson
    Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital National Health Service Trust, Norwich NR4 7UA, UK
    Diabetes Care 29:283-9. 2006
    ..Once shortened to a critical length, cells are triggered into replicative senescence. Type 2 diabetes is associated with oxidative DNA damage, and we hypothesized that telomere shortening would characterize type 2 diabetes...
  8. ncbi Monocyte matrix and ADAM metalloproteinase expression in type 2 diabetes after aspirin therapy
    Mike Sampson
    Bertram Diabetes Research Unit, Norfolk and Norwich University Hospital NHS Trust, Norwich NR4 7UY, UK
    Diabetes Res Clin Pract 71:45-51. 2006
    ..Monocyte ADAM mRNA levels do not differ between group and oral aspirin has no significant effect on these variables...
  9. ncbi Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes
    Mike J Sampson
    Bertram Diabetes Research Unit, Norfolk and Norwich University Hospital, UK
    Clin Sci (Lond) 109:189-97. 2005
    ..Male Type II diabetic subjects with PON-1 55LL homozygosity have an atherogenic NMR lipid profile independent of LDL oxidation. These data do not support an in vivo action of PON on LDL oxidation...
  10. ncbi A mobile screening programme for the cardiovascular and microvascular complications of Type 2 diabetes in primary care
    M J Sampson
    Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital, Norwich, UK
    Diabet Med 22:256-7. 2005
    ....
  11. ncbi Psychometric validation and use of a novel diabetes in-patient treatment satisfaction questionnaire
    M J Sampson
    Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
    Diabet Med 26:729-35. 2009
    ..To develop the first psychometrically validated Diabetes Treatment Satisfaction Questionnaire for in-patients (DTSQ-IP) and examine determinants of in-patient diabetes treatment satisfaction...
  12. ncbi Total and excess bed occupancy by age, specialty and insulin use for nearly one million diabetes patients discharged from all English Acute Hospitals
    Mike J Sampson
    Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
    Diabetes Res Clin Pract 77:92-8. 2007
    ..Strategies to reduce excess diabetes bed occupancy should emphasize reducing inpatient LOS in younger inpatients...
  13. ncbi An integrated mobile foot and retinal screening programme for people with Type 2 diabetes managed in primary care
    M J Sampson
    Bertram Diabetes Research Unit and Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
    Diabet Med 19:74-6. 2002
    ..To undertake a vascular and neurological assessment on the feet of all patients with Type 2 diabetes managed solely in local primary care...
  14. ncbi Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial
    PETER J CURTIS
    Department of Nutrition, Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK
    Diabetes Care 35:226-32. 2012
    ..To assess the effect of dietary flavonoids on cardiovascular disease (CVD) risk in postmenopausal women with type 2 diabetes on established statin and hypoglycemic therapy...
  15. ncbi Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes
    R C Temple
    Bertram Diabetes Centre, Norfolk and Norwich Healthcare NHS Trust, Norwich, UK
    Diabet Med 18:573-7. 2001
    ..To evaluate the impact of pregnancy on the progression of diabetic retinopathy in women with Type 1 diabetes mellitus and to identify risk factors for the progression of retinopathy during pregnancy...
  16. ncbi n-3 polyunsaturated fatty acid supplementation, monocyte adhesion molecule expression and pro-inflammatory mediators in Type 2 diabetes mellitus
    M J Sampson
    Bertram Diabetes Research Unit, Norfolk, UK
    Diabet Med 18:51-8. 2001
    ....
  17. ncbi Elevated matrix metalloproteinase-2 and -3 production from human diabetic dermal fibroblasts
    S J Wall
    School of Biological Sciences, University of East Anglia, Norwich, NR4 7TJ, U.K
    Br J Dermatol 149:13-6. 2003
    ..CONCLUSIONS: Dermal fibroblasts from normal unwounded skin are characterized by increased MMP production and this may be a primary contributing factor to the increased risk of nonhealing foot ulceration in diabetes...
  18. ncbi Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients
    M J Sampson
    Bertram Diabetes Research Unit, Department of Diabetes and Endocrinology, Norfolk and Norwich University Hospital NHS Trust, Colney, Norwich, UK
    Arterioscler Thromb Vasc Biol 22:1187-93. 2002
    ....
  19. ncbi Absence of telomere shortening and oxidative DNA damage in the young adult offspring of women with pre-gestational type 1 diabetes
    J A Cross
    Institute of Food Research, Norwich, UK
    Diabetologia 52:226-34. 2009
    ..The aim of the present study was to test the hypothesis that fetal chromosomal telomere oxidative DNA damage resulting from maternal PGDM programmes the offspring towards a senescent phenotype that is detectable in young adulthood...
  20. ncbi Association studies of insulin receptor substrate 1 gene (IRS1) variants in type 2 diabetes samples enriched for family history and early age of onset
    Eleftheria Zeggini
    Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
    Diabetes 53:3319-22. 2004
    ....